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Abstract
Background The Paleolithic diet is promoted worldwide for improved gut health. However, there is little evidence available 
to support these claims, with existing literature examining anthropometric and cardiometabolic outcomes.
Objective To determine the association between dietary intake, markers of colonic health, microbiota, and serum trimeth-
ylamine-N-oxide (TMAO), a gut-derived metabolite associated with cardiovascular disease.
Design In a cross-sectional design, long-term (n = 44, > 1 year) self-reported followers of a Paleolithic diet (PD) and controls 
(n = 47) consuming a diet typical of national recommendations were recruited. Diets were assessed via 3-day weighed diet 
records; 48-h stool for short chain fatty acids using GC/MS, microbial composition via 16S rRNA sequencing of the V4 
region using Illumina MiSeq. TMAO was quantified using LC–MS/MS.
Results Participants were grouped according to PD adherence; namely excluding grains and dairy products. Strict Paleolithic 
(SP) (n = 22) and Pseudo-Paleolithic (PP) (n = 22) groups were formed. General linear modelling with age, gender, energy 
intake and body fat percentage as covariates assessed differences between groups. Intake of resistant starch was lower in 
both Paleolithic groups, compared to controls [2.62, 1.26 vs 4.48 g/day (P < 0.05)]; PERMANOVA analysis showed differ-
ences in microbiota composition (P < 0.05), with higher abundance of TMA-producer Hungatella in both Paleolithic groups 
(P < 0.001). TMAO was higher in SP compared to PP and control (P < 0.01), and inversely associated with whole grain 
intake (r = − 0.34, P < 0.01).
Conclusions Although the PD is promoted for improved gut health, results indicate long-term adherence is associated with 
different gut microbiota and increased TMAO. A variety of fiber components, including whole grain sources may be required 
to maintain gut and cardiovascular health.
Clinical trial registrations Australian and New Zealand Clinical Trial Registry (ANZCTRN12616001703493).
Keywords Paleolithic diet · Gut health · Resistant starch · TMAO · Whole grains
Abbreviations
TMAO  Trimethylamine-N-oxide
SP  Strict Paleolithic group
PP  Psuedo-Paleolithic group
PD  Paleolithic diet
RS  Resistant starch
Introduction
The Paleolithic diet is a dietary pattern based on the hypoth-
esis that the human genome has not adapted to consume 
products of agriculture, and thus is based on consumption 
of meat, fish, eggs, nuts, fruits and vegetables; with no pro-
cessed foods, grains or dairy products included [1]. The diet 
is promoted worldwide for improved gut health [2]. How-
ever, it excludes grains and dairy, food groups that form part 
of the evidence-based national Australian and international 
dietary guidelines [3, 4].
While total dietary fiber intake can be maintained on a 
Paleolithic diet through fruit and vegetable consumption [5], 
the exclusion of whole grains and legume products alters the 
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fiber profile consumed, and in particular, results in reduc-
tions of resistant starch (RS) intake [6]. RS consistently 
improves markers of bowel health, such as increased SCFA 
levels [7–12], and long-term the effect of reduced intake has 
not been previously explored, nor the implications for micro-
bial diversity, metabolites, and other markers of gastrointes-
tinal health. While the Paleolithic diet can be classed as a 
low carbohydrate diet [5], other studies of low carbohydrate 
diets and the impact on markers for gastrointestinal health 
have been very low in total dietary fiber [13–16], thus limit-
ing comparability to the current Paleolithic dietary patterns 
and the impact on markers of gut health.
The elimination of grains, dairy and legume protein 
sources, means PDs are rich in animal-based protein, which 
may increase serum trimethylamine-N-oxide (TMAO) con-
centrations [17]. TMAO has been associated with CVD 
and atherosclerotic plaque in both animal and human mod-
els [18–21], however, there is little evidence around how 
TMAO concentrations vary with total dietary patterns in 
healthy individuals. Given the established mechanism for 
the production of TMA within the colon [18], modulations 
of the gut microbiome through dietary intervention and 
changes in fiber intake have the potential to alter circulating 
TMAO concentrations. We have previously shown that a 
short-term, 4-week intervention using the PD, did not sig-
nificantly impact TMAO, but lowered RS intake, in a small 
cohort of healthy Australian women [6]. However, longer-
term studies of a PD have not examined the relationship 
between RS intake and TMAO concentrations [22–24]. Our 
short-term, randomised, controlled intervention study, com-
prised a small sample size and the energy restricted diet may 
have limited our ability to detect significant differences in 
TMAO concentrations [6]; furthermore, we did not concur-
rently examine fecal microbiota. Given the identified link 
between TMAO concentrations and CVD [18–21], and the 
limited literature regarding long-term health implications of 
the PD, it is important to determine if the Paleolithic dietary 
pattern alters the ability of the gut microbiota to produce 
TMA. Therefore, the current cross sectional study compared 
subjects with long-term (> 1 year) adherence to a Paleolithic 
diet to those following a standard Australian diet to examine 
the impact of each diet on gastrointestinal health and poten-
tial downstream effects on cardiovascular health.
Methods
Trial design
The study was designed as a cross-sectional comparator 
study, and registered on the Australian and New Zealand 
Clinical Trial Register (ANZCTRN12616001703493) and 
approved by the Edith Cowan University, Human Research 
Ethics Committee (13402).
Participants
Recruitment for the study took place between August 
2016 and June 2017 through online advertisements. Pri-
mary inclusion criteria for the Paleolithic diet group were 
adherence to the dietary pattern for > 1 year period and 
consumption of no more than 1 serve/day of grains and 
dairy products. For inclusion in the control group, par-
ticipants needed to have made no changes to their diet 
in the previous year, and follow a relatively healthy diet 
which included grains, legumes and dairy or alternatives. 
Specific inclusion criteria for both groups were: men and 
women aged 18–70 years; willingness to complete a 3-day 
weighed diet records (3d WDR), provide blood, urine and 
stool samples; non-smoker, not participating in other stud-
ies and had BMI < 30 kg/m2. Subjects were excluded if 
they had taken antibiotics in the previous 6-month, had a 
past or present digestive disorder, surgery on the gastro-
intestinal tract, used anti-hypertensive or lipid or glucose-
lowering medication, previous cardiovascular events or 
diagnosed CVD. Participants were screened via email or 
phone confirming exclusion/inclusion criteria were met 
and provided written informed consent prior to study com-
mencement. Participants completed a diet history inter-
view, followed by a 3d WDR, including 2 week days and 
1 weekend day. Samples collected were a 24-h urine and 
fasted (overnight) blood sample. Portable freezers (Waeco-
CF-40,Dometic, Australia) were supplied to collect all 
stool samples over a 48-h period. Physical activity was 
assessed by the International Physical Activity Question-
naire [25].
Validity of dietary intake data
Dietary data provided by the 3d WDR were validated by 
urine nitrogen analysed using a 1 in 50 dilution of urine 
sample on a Shimadzu Total Carbon and Nitrogen Analyser, 
TOC-Vcsh/TMN-1 (Shimadzu, Japan). Total nitrogen intake 
was determined by dividing protein intake by 6.25 [26], with 
an acceptable intake to excretion ratio set at 80% ± 24% [27]. 
Those with an intake to excretion ratio outside of this range 
were deemed to be protein intake under or over reporters. 
Potential energy under reporters were identified utilising the 
Goldberg cut point [28]. Those who were identified as under 
reporting both protein and energy were defined as unreliable 
dietary reporters. Confirmation that the 3d WDR was repre-
sentative of usual dietary intake was achieved by statistical 
analysis of the energy and protein intake of both methods.
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Paleolithic scoring protocol
Due to individual differences in interpretation of the Paleo-
lithic dietary pattern noted during data-entry of the 3d WDR, 
a post hoc scoring protocol was developed to rank adherence 
to the Paleolithic diet principles, namely the exclusion of 
grain and dairy products. Those who consumed < 1 serve 
per day of grains and dairy, in-line with the inclusion crite-
ria, were allocated to the Strict Paleolithic (SP), while those 
who consumed > 1 serve per day of grains and/or dairy were 
allocated to the Pseudo-Paleolithic group (PP).
Outcomes assessment
Dietary intake
The diet history and 3d WDR data were entered into Food-
Works v8.0 [29], by the same assessor, a registered nutri-
tionist with advanced competencies in dietary analysis. All 
food records were checked for completeness. Minimum and 
maximum RS content of each food item, utilised in the 91 
food items generated from the 3d WDR, were determined 
using methods described elsewhere [6].
Anthropometric measures
Subjects were fasted for 2-h prior to the clinic appointment 
and reported dressed in tightly fitting gym clothes. Blood 
pressure measurement was conducted, in duplicate, on the 
right arm with an Omron IA1B Automated Blood Pressure 
Device (Omron Health Care Ltd, Japan) at heart level, 1 min 
apart. The mean of the two systolic and diastolic measures 
respectively were recorded as per the protocol described by 
the American Heart Foundation [30]. Standing height to the 
nearest 0.1 cm was recorded using a SECA 763 digital stadi-
ometer (SECA Ltd, USA). Waist circumference was meas-
ured to the nearest 0.1 cm at the narrowest part of the waist 
by a Lufkin steel tape measure, following standardised ISAK 
techniques [31]. The BodPod body composition chamber 
(Cosmed, USA) calculated both weight and body fat per-
centage (to the nearest 0.001 kg and 0.01%, respectively). 
As per the manufacturer’s protocol, hair was covered with a 
tightly fitted cap, with all jewellery and footwear removed.
Stool form and biochemistry
Upon arrival at the university, the Bristol stool number 
(as reported by the participant at collection time [32]) was 
recorded. Each individual sample was weighed and the total 
number of samples provided over the 48-h period allowed 
the calculation of stool frequency (bowel motions/day).
Individual stool samples were stored at − 80 °C until sam-
ple processing, where they were defrosted at 4 °C overnight. 
Samples from the same participant were combined and 
homogenised manually on ice for at least 1 min prior to 
weighing and aliquoting for each individual assay. SCFA 
analysis was undertaken using 1–1.5 g aliquots of stool using 
methods described by Bajka et al. [33], with the addition of 
a freeze–thaw distillation prior to GC analysis.
Moisture content was calculated by freeze-drying, in 
duplicate, 40 g of pre-aliquoted stool sample for 7 days 
using a Christ LD-alpha freeze drier (Martin Christ Ltd., 
Germany). Moisture content, expressed as a percentage, was 
calculated from the mean of the two individual moisture 
measurements.
Blood biochemistry
Participants reported to pathology for a blood test on the 
morning after completion of the 3WDR, after an overnight 
fast. Lipids were determined using standard enzymatic 
techniques (Abbott Architect c16000 assay) by Pathwest, 
a National Association of Testing Laboratories (NATA) 
accredited laboratory. Serum samples, stored at − 80 °C, 
were analysed for TMAO at the School of Science Ana-
lytical facility, Edith Cowan University, using the method 
described by Le et al. [34].
Microbiota analysis
The microbial analysis were conducted at the WA Human 
Microbiome Collaboration Centre, Curtin University, utilis-
ing the QIAmp PowerFecal DNA Kit for DNA extraction 
and Illumina MiSeq platform for sequencing. Full methods 
are available in the supplementary information.
Statistical methods
A priori power calculations were determined using G-Power 
software [35] and were based on reductions to our primary 
outcome variable, fecal butyrate excretion. Available lit-
erature suggested a medium to large Cohen’s effect size 
(d = 0.595) could be expected [13], providing sample size 
requirement of n = 72 at 80% power and α = 0.05, however, 
given fiber intake can be maintained on a Paleolithic diet, a 
more conservative estimate was determined using a medium 
effect size (d = 0.5). The actual sample requirement was 
therefore deemed to be between a total of n = 72 and n = 102, 
with n = 36 and n = 51 per group, respectively.
Data were analysed using SPSS v24.0 [36]. Non-normally 
distributed data were  log10 transformed prior to analysis and 
back-transformed to allow calculation of the estimated mar-
ginal means and corresponding 95% confidence intervals. 
General linear modelling was used to compare the strati-
fied Paleolithic vs control groups. Post hoc Bonferroni cor-
rections were applied to P values from the three groups 
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analysis. Amongst the entire cohort, exploration of associa-
tions between dietary intake, blood and stool biochemistry 
were conducted using linear regression. All models included 
age, gender, energy intake and body fat percentage as covari-
ates, with additional covariates used where appropriate. Sig-
nificance for the study was set at P < 0.05.
Microbiota analysis was conducted using Primer 7 (Quest 
Research, NZ) with permutation multivariate analysis of 
variance (PERMANOVA) [37]. At the phylum and genus 
level, relative abundance data were square or fourth root 
transformed, prior to the calculation of a Bray–Curtis simi-
larity matrix. Principal coordinates analysis (PCO) was used 
to examine possible differences or separations among the 
groups visually at the 2-D level. This was followed by PER-
MANOVA to formally assess differences between groups. 
Dissimilarity percentage (SIMPER) analysis was used to 
determine the contribution of individual phyla and genera 
driving the average dissimilarities between groups based 
on the Bray–Curtis similarity matrix. Distance-based linear 
modelling (DistLM) was utilised to describe the patterns in 
the microbiota using the dietary intake variables. Measures 
of diversity were calculated using the Shannon and Simpson 
indices. The Bacteriodetes:Firmicutes ratio was calculated 
and exported to SPSS v24.0 (IBM Corporation, USA) [36] 
for analysis.
All analyses were conducted with and without the inclu-
sion of participants identified as unreliable dietary reporters. 
Where the inclusion of these participants did not influence 
statistical significance of our findings, the reported results 
include all participants.
Results
Participants
As shown in Fig. 1, 90 subjects completed the study with 
partial data available for an additional control subject. Par-
ticipant characteristics are presented in Table 1. No signifi-
cant differences were found between groups for age, height, 
energy intake or physical activity. The average length of 
time Paleolithic participants had followed the diet was 
2.38 ± 1.08 years. In terms of being representative of long-
term dietary intake, bivariate correlations of energy and pro-
tein with the diet history showed good agreement (R = 0.596 
and 0.763 respectively, P < 0.01) and a one sample t test 
showed the energy and protein intake determined from the 
3d WDR and the diet history were not significantly different 
(P = 0.623 and 0.059 respectively). A Bland–Altman plot 
[38] confirmed acceptable agreement between urinary nitro-
gen and calculated nitrogen intake from protein intake (data 
not shown); and a one-sample t test showed no difference 
between these variables (P = 0.337). Five participants were 
identified as under-reporting both energy and protein intake, 
two from the SP group and three from the control group. The 
scoring protocol was used to rank participants according to 
adherence to the diet (Table 1). Body weight was signifi-
cantly greater in the Pseudo-Paleolithic (PP) group, when 
compared to the controls, but there were no other differences 
between groups identified.
Dietary intake
Total dietary fiber (TDF) intake in the SP group was not 
different from that of the control (Table 2), however the PP 
group had fiber intake below the recommended Australian 
adequate intake (AI) of 25 g/day. In line with the signifi-
cantly lower TDF intake in the PP group, both soluble and 
insoluble fibre intake was also lower, when compared to the 
control group. RS intake was significantly lower in the SP 
and PP groups at both minimum and maximum estimated 
intakes (Table 2). Despite the low carbohydrate intake, 
vegetable intake in the SP group met the Australian rec-
ommendations of 5 serves per day [3], with a mean intake 
significantly higher than that of the control group. Across the 
whole cohort, total fiber intake was inversely associated with 
body weight [t(86) = − 4.22, partial r = − 0.414, P < 0.001), 
body fat percentage [t(86) = − 2.282, partial r = − 0.239, 
P = 0.025] and waist circumference [t(85) = − 3.397, par-
tial r = − 0.346, P = 0.001]. Protein intake as percentage of 
energy and absolute intake in grams per day, was signifi-
cantly higher in the SP group, when compared to the con-
trol and PP (Table 2). Fat intake was significantly higher 
in both Paleolithic groups, when compared to the control 
(Table 2). Saturated fat intake in all dietary groups exceeded 
the recommended intake of 10% of energy [3], with intakes 
in both of the Paleolithic groups more than double the rec-
ommended Australian and international levels [3, 39].
Blood biochemistry
Total serum cholesterol was higher in the PP, when com-
pared to the control group (Table 3). High-density lipopro-
tein (HDL) cholesterol was significantly higher in the SP 
and PP groups, when compared to the control group and led 
to non-significant differences among the groups in the total 
cholesterol:HDL cholesterol ratio (Table 3). Total serum 
cholesterol concentrations were inversely associated with 
carbohydrate intake, both expressed as g/day [t(77) = − 2.47, 
partial r = − 0.271, P = 0.016] and as a percentage of energy 
[t(77) = − 2.54, partial r = − 0.280, P = 0.013]. Further explo-
ration showed significant negative association with the mini-
mum [t(77) = − 3.329, partial r = − 0.355, P = 0.001], and 
maximum RS intakes [t(77) = − 2.922, partial r = − 0.316, 
P = 0.005] and whole grain intake [t(77) = − 2.032, 
r = − 0.226, P = 0.046].
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TMAO was significantly higher in the SP group, 
when compared to the control group (Table  3). TMAO 
concentrations were associated with servings of red 
meat [t(67) = 3.372, partial r = 0.357, P = 0.001], and 
inversely associated with total grain [t(83) = − 3.143, 
partial r = − 0.335, P = 0.002] and whole grain intake 
[t(83) = − 2.973, partial r = − 0.319, P = 0.004], respectively.
Stool biochemistry
There was no difference in daily stool weight or form but 
stool frequency was greater in the PP group when com-
pared to the control group (Table 3). Regression analysis 
across the whole cohort showed stool frequency was sig-
nificantly associated with nut and seed consumption after 
adjustment for energy intake [t(87) = 2.14, partial r = 0.223, 
P = 0.036], with each serve of nuts increasing motions/day 
by 0.12. There were no significant differences in SCFA 
excretion between groups, however, total SCFA excre-
tion was associated with fiber intake [t(84) = 2.331, partial 
r = 0.247, P = 0.022], but not with carbohydrate (expressed 
as a percentage of energy and g/day), grains, whole grains, 
or RS intake. Total dietary fibre predicted butyrate excre-
tion [t(84) = 2.232, partial r = 0.237, P = 0.028] but no rela-
tionships with wholegrains, grains and resistant starch were 
noted. Vegetable intake significantly predicted total SCFA 
excretion [t(84) = 2.27, partial r = 0.240, P = 0.026] and fur-
ther analysis showed the association was due intakes of the 
dark green vegetable group [t(84) = 2.047, partial r = 0.218, 
P = 0.044], with similar associations seen for acetate excre-
tion; vegetables were associated with acetate excretion 
[t(84) = 2.69, partial r = 0.281, P = 0.009], and subgroup 
analysis showed the association was due to the dark green 
vegetables [t(5,84) = 2.52, partial r = 0.265, P = 0.014].
Fig. 1  Flow diagram of the study. Of the 231 enquiries received, 92 participants were accepted into the study. Two participants in the control 
group withdrew due to illness, with partial data available for one subject. 44 Paleolithic and 46 controls completed the study data collection
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Microbiota profiles
The sequence data yielded 929 denoised operational taxo-
nomic units (OTU) with an average 38,899 reads per sample 
(ranging from 2647 to 107,597 reads). Two participants from 
the control group were inadvertently tagged with identical 
forward and reverse barcodes and were excluded from the 
analysis. OTU comprising less than 0.01% of the total reads 
were eliminated (514 OTU), leaving 415 available for analy-
sis. Five sequence controls comprised total reads between 
3409 and 11,560. Five OTU not related to the gut micro-
biota, were present primarily in the blank samples, totalling 
11,210 reads and were removed from the analysis. One OTU 
(432 reads) comprised human mitochondrial DNA and were 
also excluded from the analysis. The final dataset included 
410 total OTU’s, which was converted to relative abundance 
before importing to PRIMER 7 [37] for analysis.
The microbial composition was analysed both at the 
phylum and at the genus level to examine major and more 
specific shifts in the gut microbiota between the three 
dietary groups. At the phylum level, there was no differ-
ence between groups for measures of diversity (Shannon 
and Simpson indices) or species richness between the three 
groups (Table S1). However, PERMANOVA analysis at the 
phylum level showed significant differences in microbiota 
composition between the control and PP groups (P = 0.048) 
and the SP and PP groups (P = 0.001). No difference was 
observed between the SP and control groups. SIMPER 
analysis indicated that group differences were driven by the 
relative abundances of Bacteriodetes, Firmicutes and Ver-
rucomicrobia phyla. The relationship between Bacteriodetes 
and Firmicutes has been linked with increased body fat [40, 
41], therefore, the overall Bacteriodetes:Firmicutes ratio was 
calculated, and between-group differences were evaluated 
using general linear modelling, with the addition of age, 
gender, energy intake and body fat percentage as covari-
ates in the model. No differences were observed between 
the three groups. Although, in the entire cohort body fat 
percentage (partial R = − 0.33, P = 0.032) and energy intake 
(partial R = − 0.23, P = 0.033) were significant predictors of 
the ratio in a linear regression model.
At the genus level, there were no significant differences 
between the three groups, in measures of Shannon or Simp-
son diversities, and species richness. PERMANOVA anal-
ysis with covariates age, gender, energy intake and body 
fat percentage, showed there were significant differences 
between the SP and control (P = 0.004) and PP and control 
(P = 0.04), with no significant difference between the two 
Paleolithic groups.
DistLM showed a significant influence of vegetable intake 
(P < 0.01), in addition to significant influences of whole 
grains (P < 0.01), RS maximum estimation (P < 0.01), total 
carbohydrate (P < 0.01) and total fat (P = 0.04) on the micro-
bial composition (Fig. 2).
Having established significant differences at the genera 
level, SIMPER analysis was used to determine the species 
which contributed to the differences identified between 
groups. The average dissimilarity between SP and control 
groups was 27.25%, SP and PP 26.27% and PP and control 
27.13%. Abundant genera driving dissimilarities between 
groups were Bacteriodes, Faecalibacterium, Blatia, Rumi-
noclostridium, Alistipes, Roseburia, Ruminococcus, Lachno-
spiracea Incertae sedis, Ruminoclostridium, Anaerostipes, 
Gemmiger, Irregularibacter, Akkermansia. After adjustment 
for the study covariates, age, gender, energy intake and body 
fat percentage, three of these genera were identified as being 
Table 1  Participant 
characteristics by dietary group
**P < 0.01 different from control group. Means calculated using general linear modelling with the addition 
of age and gender as covariates
a Unadjusted mean
b PAL Score derived from PAL ranking (from IPAQ Scoring Protocol) [40] and converted to PAL score 
[41]
Control
Mean (95% CI)
Strict Paleolithic (SP)
Mean (95% CI)
Pseudo-Paleolithic (PP)
Mean (95% CI)
N 47 22 22
Age (years)a 38.96 (35.02, 42.90) 41.49 (35.46, 47.53) 45.33 (39.69, 50.96)
Height (cm) 169.6 (167.9, 171.4) 169.8 (167.1, 172.5) 172.8 (170.3, 175.3)
Weight (kg) 69.19 (65.58, 72.79) 70.23 (64.74, 75.72) 79.08 (73.89, 84.27)**
BMI (kg/m2) 23.94 (22.78, 25.10) 24.33 (22.56, 26.10) 26.39 (24.72, 28.07)
Systolic blood pressure (mmHg) 120 (114, 125) 116 (109, 124) 114 (107, 125)
Diastolic blood pressure (mmHg) 79 (75, 83) 75 (70, 81) 77 (72, 82)
Waist circumference (cm) 81.3 (78.1, 84.5) 83.0 (78.2, 87.8) 86.1 (81.7, 90.6)
Body fat (%) 22.68 (20.21, 25.14) 22.38 (18.63, 26.13) 25.96 (22.41, 29.50)
Energy intake (kJ) 9384 (8800, 9968) 9171 (8282, 10059) 9812 (8972, 10652)
Physical activity (PAL)b 1.82 (1.79, 1.86) 1.87 (1.81, 1.93) 1.83 (1.77, 1.86)
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Table 2  Energy, macronutrient and food group intake by dietary group
Dietary variable Control
Mean (95% CI)a,b 
(n = 47)
Strict Paleolithic
Mean (95% CI)b 
(n = 22)
Effect size 
(SP vs 
control)
Pseudo-Paleolithic
Mean (95% CI)b  
(n = 22)
Effect size 
(PP vs con-
trol)
Overall dietary 
effect P  valuec
Energy intake (kJ) 9187 (8599, 9774) 8955 (8076, 9834) − 0.13 9820 (9005, 10635) 0.33 0.285
Protein (g) 92.16 (83.69, 100.63) 118.07 (105.69, 
130.44)**
1.02 102.7 (90.62, 114.77) 0.39 0.001
Protein (% of energy) 18.49 (16.87, 20.12) 23.63 (21.25, 26.00)** 1.02 20.13 (17.81, 22.45) 0.39 0.001
Carbohydrate (g) 202.62 (187.84, 217.41) 99.19 (77.60, 120.79)** − 2.33 81.40 (60.34, 102.47)** − 2.59 < 0.001
Carbohydrate (% of 
energy)
38.03 (35.49, 40.57) 16.75 (13.03, 20.46)** − 2.79 16.41 (12.79, 20.03)** − 2.69 < 0.001
Sugars (g) 75.58 (66.05, 85.11) 51.77 (37.85, 65.68)** − 0.83 44.34 (30.76, 57.91)** − 1.04 < 0.001
Starch (g) 124.56 (112.87, 136.26) 45.86 (28.78, 62.95)** − 2.24 34.74 (18.07, 51.4)** − 2.43 < 0.001
Total fat (g) 82.53 (76.33, 88.72) 117.91 (108.86, 
126.96)**
1.90 133.16 (124.34, 
141.99)** 
2.58 < 0.001
Fat (% of energy) 36.45 (33.9, 39) 52.95 (49.22, 56.67)** 2.15 56.96 (53.33, 60.6)** 2.54 < 0.001
Saturated fat (g) 27.34 (22.77, 31.9) 45.51 (38.84, 52.18)** 1.33 52.47 (45.97, 58.98)** 1.74 < 0.001
Saturated fat (% of 
energy)
12.02 (10.05, 13.99) 20.59 (17.71, 23.47)** 1.45 22.09 (19.28, 24.9)** 1.61 < 0.001
Polyunsaturated fat (g) 15.17 (13.21, 17.14) 16.86 (13.98, 19.73) 0.29 17.47 (14.67, 20.28) 0.37 0.295
Monounsaturated fat 
(g)
32.96 (29.63, 36.28) 45.01 (40.16, 49.86)** 1.21 52.28 (47.55, 57.02)** 1.84 < 0.001
Cholesterol (mg) 324.19 (225.29, 423.08) 708.28 (563.84, 
852.73)**
1.29 685.00 (544.10, 
825.90)**
1.15 < 0.001
Total dietary fiber (g) 29.66 (26.36, 32.96) 27.41 (22.59, 32.23) − 0.23 20.79 (16.09, 25.49)* − 0.85 0.006
Soluble dietary fiber 
(g)
11.99 (10.45, 13.53) 10.78 (8.54, 13.03) − 0.26 7.62 (5.43, 9.81)** − 0.90 0.004
Insoluble dietary fiber 
(g)
17.07 (15.11, 19.03) 16.17 (13.3, 19.04) − 0.15 12.87 (10.07, 15.66)* − 0.68 0.036
Resistant starch mini-
mum (g)
4.48 (3.89, 5.06) 2.62 (1.77, 3.47)** − 1.03 1.26 (0.43, 2.09)** − 1.75 < 0.001
Resistant starch maxi-
mum (g)
14.16 (12.24, 16.07) 6.13 (3.34, 8.93)** − 1.35 2.95 (0.22, 5.68)** − 1.85 < 0.001
Alcohol (g) 7.07 (3.73, 10.4) 8.31 (3.44, 13.19) 0.12 10.34 (5.59, 15.09) 0.31 0.488
Vegetables serves/
day (fresh equivalent 
150–350 kJ)
3.83 (2.99, 4.66) 6.68 (5.51, 7.84)** 1.12 4.31 (3.17, 5.44) 0.16 < 0.001
Dark green vegetable 
serves/day (fresh 
equivalent 100 kJ)
0.39 (0.17, 0.61) 1.28 (0.97, 1.59)** 1.34 0.70 (0.41, 1.00) 0.45 < 0.001
Nuts and seeds (30 g 
protein equivalent)
0.82 (0.48, 1.15) 1.07 (0.59, 1.56) 0.26 1.32 (0.84, 1.79) 0.48 0.167
Red meat serves/
day (20 g protein 
equivalent)
0.44 (0.21, 0.66) 0.80 (0.47, 1.13) 0.52 0.77 (0.45, 1.09) 0.46 0.066
Eggs serves/day (13 g 
protein equivalent)
0.20 (0.09, 0.30) 1.05 (0.72, 1.38)** 0.87 0.89 (0.57, 1.21)* 0.63 < 0.001
Total grains serves/
day (14–16 g starch 
equivalent)
6.14 (5.29, 7.04) 0.19 (0.03, 0.47)** − 3.80 0.63 (0.30, 1.08)** − 3.07 < 0.001
Whole grain serves/
day (14 g starch 
equivalent)
2.91 (2.28, 3.61) 0.09 (0.00, 0.34)** − 2.32 0.16 (0.01, 0.46)** − 2.09 < 0.001
Total dairy serves/day 
(300 mg calcium 
equivalent)
1.60 (1.25, 2.0) 0.17 (0.04, 0.37)* − 1.26 0.87 (0.54, 1.27)* − 0.73 < 0.001
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significantly different between groups, Bifidobacteria, Rose-
buria, and Hungatella (Fig. 3a–c).
Relative abundance of Hungatella was significantly and 
inversely associated with grain consumption in a linear 
regression model after adjustment for age, gender, body fat 
and stool frequency (partial r = − 0.298, P = 0.006). Relative 
abundance of Roseburia was significantly related to total 
grain (partial r = 0.315, P = 0.002), whole grain (partial 
r = 0.298, P = 0.004) and carbohydrate consumption (par-
tial r = 0.297, P = 0.004), but not with dietary fiber, or RS 
minimum or maximum estimates. Similar to Roseburia, Bifi-
dobacteria abundance was related to total grain consumption 
(partial r = 0.266, P = 0.008) and the percentage of energy 
derived from carbohydrate (partial r = 0.221, P = 0.028), 
but not with RSi, whole grains or total dietary fiber. In a 
linear regression model, relative abundances of Roseburia 
and Bifidobacteria were significantly and inversely corre-
lated with the abundance of Hungatella [t(87) = − 2.1, partial 
r = − 0.2, P = 0.03]. In line with the TMAO findings, relative 
abundance of Hungatella was also significantly associated 
with servings of protein foods per day [t(87) = − 2.84, partial 
r = 0.27, P = 0.006].
Discussion
This study evaluated the gastrointestinal implications of low 
carbohydrate, high fat, Paleolithic style diets through com-
parison with a cohort of healthy Australians in a cross-sec-
tional study design. Consumption of a long-term Paleolithic 
diet was associated with markedly higher serum TMAO con-
centrations, but only in those who adhered to the diet strictly. 
Romano et al. [42], identified six species of bacteria asso-
ciated with choline consumption and production of TMA, 
of which, one was identified in our cohort, Clostridium 
hathewayi, originating from the genera Hungatella. We did 
not identify the other species reported by Romano et al. [42], 
although our methods of short amplicon sequencing are not 
typically used to identify individual species, but rather pro-
vide robust data at the genus level. It is therefore possible the 
other species were present, but not identified at the species 
level in our cohort. Nonetheless, the relative abundance of 
the Hungatella genus was significantly higher in both the SP 
and PP groups. Our results show that serum TMAO concen-
trations and Hungatella abundance were inversely associated 
with total and whole grain consumption, indicating these 
food groups may downregulate the ability of Hungatella to 
dominate or interfere with the production of TMA. Notably, 
TMAO concentrations in the PP group were not statistically 
different from the controls, despite the increased Hungatella 
abundance and small to medium effect size noted. The strati-
fication of the Paleolithic group into two groups may have 
reduced our ability to detect significance of this outcome 
variable. Furthermore, the lower overall fiber and higher fat 
content of the PP diet may have influenced the fermentative 
capacity of the microbiota to produce TMA, given high fat 
diets may attenuate the fermentation response [43].
Bergeron et al. [44] detected changes in TMAO concen-
trations after a 2-week dietary intervention with 52 subjects 
and found low carbohydrate diets, high in RS, were associ-
ated with increased plasma TMAO. Conversely, in the cur-
rent study TMAO was not associated with RS, but inversely 
associated with grain intake. This may indicate that other 
components of the grain carbohydrate and fiber are respon-
sible for modulating abundances of Hungatella. Bergeron 
et al. [44] did not report food group intake for the interven-
tion diets, which limits comparability with our study. In sup-
port of the findings presented here is the identification of the 
genera associated with producing TMA in the fecal micro-
biota [42], in addition to the statistical association found 
with red meat intake, a known TMA precursor food [45].
While there were no observed differences in measures of 
fecal microbiota diversity (α-diversity), a significant group 
difference (β-diversity) at both the phylum and genus levels 
were reported. An inverse association was found between the 
Bacteriodetes:Firmicutes ratio and body fat, supporting pre-
vious research showing a reduced ratio was associated with 
obesity [40, 41, 46]. At the genus level, different community 
structures were associated with intakes of vegetables, dietary 
fat, RS, whole grain and dietary fiber. The direction of the 
shift in microbiota composition was similar for vegetable 
intake, whole grains, RS and dietary fiber and is likely to be 
Table 2  (continued)
P values for stratified Paleolithic groups were adjusted using post hoc Bonferroni correction [43]
Significant P values are in bold
a General linear modelling used to determine estimated marginal means and the difference between control and the overall Paleolithic groups 
after adjustment for age, gender, energy intake and body fat percentage.**P ≤ 0.01 different from control group, *P ≤ 0.05 different to control 
group
b General linear modelling used to determine estimated marginal means and the difference between control, strict Paleolithic and Pseudo-Paleo-
lithic groups after adjustment for age, gender, energy intake and body fat percentage.**P ≤ 0.01 different from control group, *P ≤ 0.05 different 
to control group.  P < 0.01 different from Strict Paleolithic group,  P < 0.05 different from the SP group
c Significance of the overall general linear model for the three group analysis. Effect sizes reported using Cohen’s d, with a value of 0.2 represent-
ing a small effect, 0.5 a medium effect and 0.8 a large effect
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Table 3  Biochemistry results by dietary group
Significant P values are in bold
a General linear modelling used to determine estimated marginal means and the difference between control and the overall Paleolithic groups 
after adjustment for age, gender, energy intake and body fat percentage.**P ≤ 0.01 different from control group, *P ≤ 0.05 different from control 
group
b General linear modelling used to determine estimated marginal means and the difference between control, strict Paleolithic and Pseudo Paleo-
lithic groups after adjustment for age, gender, energy intake and body fat percentage.**P ≤ 0.01 different from control group, *P ≤ 0.05 different 
from control group
c Significance of the overall general linear model for the three group analysis. Effect sizes reported using Cohen’s d, with a value of 0.2 represent-
ing a small effect, 0.5 a medium effect and 0.8 a large effect
d LDL Cholesterol reported is calculated LDL. P values for stratified Paleolithic groups adjusted using post hoc Bonferroni correction [43]
e Log transformation conducted prior to analysis
Biomarker Control
Mean (95% CI)a,b 
(n = 46)
Strict Paleolithic
Mean (95% CI)b 
(n = 22)
Effect size (strict 
Paleolithic vs 
control)
Pseudo-Paleolithic
Mean (95% CI)b 
(n = 22)
Effect size 
(Pseudo-Paleolithic 
vs control)
Overall dietary 
effect P  valuec
Blood biochemistry
Total Cholesterol 
(mmol/L)
4.88 (4.51, 5.26) 5.02 (4.48, 5.56) 0.13 5.60 (5.10, 6.11)* 0.65 0.050
LDL  Cholesterold 
(mmol/L)
3.00 (2.70, 3.30) 3.10 (2.66, 3.53) 0.12 3.49 (3.09, 3.90) 0.55 0.113
HDL Cholesterol 
(mmol/L)
1.43 (1.29, 1.57) 1.69 (1.49, 1.89)** 0.64 1.79 (1.61, 1.98)* 0.88 0.003
Total Cholesterol/
HDL Ratio
3.49 (3.21, 3.77) 3.14 (2.73, 3.55) − 0.41 3.25 (2.87, 3.64) − 0.28 0.122
Triglycerides 
(mmol/L)
0.94 (0.88, 1.0) 0.86 (0.79, 0.94) − 0.49 0.84 (0.77, 0.91) − 0.60 0.049
Serum TMAO 
(µM)e
3.93 (2.79, 5.55) 9.53 (5.86, 15.49)** 0.86 5.47 (3.42, 8.75) 0.32 0.008
Stool markers
Stool weight (g/day 
wet weight)
194.57 (161.7, 
227.43)
248.81 (200.55, 
297.06)
0.55 233.04 (186.03, 
280.05)
0.37 0.099
Frequency (motions 
per day)
1.37 (1.19, 1.54) 1.60 (1.35, 1.85) 0.46 1.91 (1.67, 2.16)** 1.03 0.001
Bristol number [31] 4.12 (3.75, 4.48) 4.3 (3.76, 4.84) 0.18 4.54 (4.02, 5.07) 0.38 0.338
Moisture (%) 73.96 (72.04, 75.89) 74.69 (71.86, 77.52) 0.12 74.5 (71.74, 77.26) 0.09 0.880
pHe 7.19 (7.05, 7.36) 7.19 (6.97, 7.41) − 0.33 7.18 (6.97, 7.4) − 0.06 0.974
Residual fecal fat 
(%)e
1.09 (0.69, 1.5) 1.16 (0.57, 1.75) 0.07 1.70 (1.13, 2.27) 0.49 0.165
Acetate excretion 
(mmol/day)e
7.80 (6.18, 9.86) 10.52 (7.46, 14.86) 0.41 9.06 (6.49, 12.68) 0.19 0.288
Propionate excre-
tion (mmol/day)e
2.36 (1.87, 2.98) 2.76 (1.96, 3.89) 0.80 2.82 (2.02, 3.94) 0.70 0.546
Isobutyrate excre-
tion (mmol/day)e
0.27 (0.23, 0.32) 0.34 (0.26, 0.44) 0.42 0.34 (0.27, 0.44) 0.41 0.152
Butyrate excretion 
(mmol/day)e
2.21 (1.72, 2.84) 2.86 (1.98, 4.13) 0.33 2.85 (1.99, 4.07) 0.32 0.315
Isovalerate excre-
tion (mmol/day)e
0.39 (0.33, 0.46) 0.45 (0.36, 0.58) 0.29 0.48 (0.38, 0.61) 0.39 0.255
Valerate excretion 
(mmol/day)e
0.30 (0.25, 0.36) 0.37 (0.29, 0.49) 0.40 0.38 (0.29, 0.49) 0.41 0.136
Caproate excretion 
(µmol/day)e
0.05 (0.04, 0.08) 0.06 (0.03, 0.11) 0.05 0.08 (0.04, 0.15) 0.28 0.618
Total SCFA excre-
tion (mmol/day)e
13.74 (11.02, 17.14) 17.91 (12.94, 24.83) 0.38 16.41 (11.94, 22.54) 0.25 0.299
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beneficial, given the large body of evidence associated with 
health benefits from consumption of these food groups [3, 
47–54]. Conversely the direction of the shift in microbiota 
composition associated with fat consumption was in the 
opposite direction and suggests a more deleterious profile. 
Reductions to core bacteria including Roseburia, as seen in 
the current study, have been associated with inflammatory 
bowel diseases [55]. In animal models, high-fat diets have 
been shown to drive obesity independently of the composition 
of the microbiota [56]. There were reductions in the Paleo-
lithic dietary groups to genera Roseburia and Bifidobacterium, 
known to metabolise carbohydrate and produce butyrate. 
Moreover, low abundances of known beneficial genera such as 
Bifidobacterium in the Paleolithic groups support the findings 
of Brinkworth et al. [13], who reported low abundances of this 
genera after an 8 week low-carbohydrate diet, comprising 58% 
fat [13]. A decrease in relative abundance of Bifidobacterium 
has been previously associated with irritable bowel syndrome, 
and obesity [57], however, these disorders have also been 
associated with lower fecal excretion of acetate and butyrate, 
which was not found in the current cohort. Given that total fat 
intake was associated with microbiota composition at both the 
phylum and genus level, and positively correlated with body 
weight, the differences observed in microbiota composition 
are unlikely to be beneficial.
Supporting our previous findings from a short-term 
intervention using the Paleolithic diet [6], the elimination 
of the grains food group on a Paleolithic diet resulted in 
a significantly lower intake of RS than the control group, 
despite no significant differences found in total soluble or 
insoluble fiber intakes. Intakes of RS in the control group 
were slightly higher than previous estimates of Australian 
intakes of 3.4–9.4 g/day [58] and may be due to higher con-
sumption of whole grains than the average Australian intake 
of 1.5 serves/day [59]. Both groups consumed less than the 
proposed 20 g RS/day required for bowel health [60] and 
may be an area for focus in future interventions.
Despite the differences in RS intake, we did not observe any 
differences between groups in SCFA excretion. While this was 
an unexpected finding, the high intake of saturated fat in the 
Paleolithic groups may have influenced the results, given Fava 
et al. [61], showed fecal SCFA concentrations were higher 
following a 4-week diet comprising 17% saturated fat in 88 
participants at risk of metabolic syndrome. It is not yet under-
stood whether saturated fat leads to changes in fermentation 
patterns or alterations to colonic uptake of SCFA. Differences 
Fig. 2  Distance-based redundancy plot, showing the effect of dietary 
intake, overlaid with serum TMAO, and microbiota composition. The 
added dietary variable vectors show the correlation between the die-
tary factor and the microbiota composition. The length of the line is 
indicative of the strength of the association. Whole grains (P < 0.01), 
carbohydrate (P < 0.01) and RS (P < 0.01) are associated with a shift 
in composition towards the top of the plot, consistent with microbi-
ota composition of the control group. However, dietary fat (P = 0.04) 
was associated with a shift in the opposite direction, with vegetables 
(P < 0.01) falling in between the two groups. Consistent with the 
serum TMAO increase in the SP group, TMAO is closely aligned 
with microbiota composition, total fat and red meat consumption (P 
trend = 0.09)
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in microbiota composition attributed to the intervention diets 
used by Fava et al. [61] were assessed using fluorescence in situ 
hybridisation (FISH), which limits comparability with the cur-
rent study. In addition, the lack of difference we observed for 
SCFA excretion may have been due to the differences in the 
sites of fermentation for grains as opposed to vegetables, with 
the latter likely to be fermented in the distal colon due to the 
difference in fiber structure, although there is little literature 
in this area. Even though fecal acetate concentration has been 
inversely associated with acetate absorption [62] fecal SCFA 
may not provide a sensitive enough marker to estimate differ-
ences in total fermentation along the colon. [63].
Previous short-term interventions using the Paleolithic diet 
have found increases to HDL cholesterol in diabetics [64], 
but not in healthy populations [5, 65–67], however, the latter 
also reported reductions to total and LDL cholesterol, in addi-
tion to significant weight loss, which may have influenced 
HDL concentrations. Further, a 2-year intervention showed 
no significant change in total or HDL cholesterol, despite 
significant reductions in triglycerides over the intervention 
period [23]. The current data showed small, but significantly 
greater HDL concentrations in the Paleolithic groups, which 
were associated with the reduction in carbohydrate intake, 
and increase in saturated fat consumption. The findings 
reported here support previous work showing that saturated 
fat consumption increases concentrations of calculated HDL 
cholesterol [68]. The current study also shows a significant 
relationship between saturated fat consumption and total 
cholesterol levels. A systematic review and meta-analysis 
showed that for every 1 mmol/L increase in total cholesterol, 
the relative risk of CVD was 1.20 for women (95% CI 1.16, 
1.24) and 1.24 in men (1.20, 1.28) [69]. Therefore, while 
there may be conflicting evidence surrounding the specific 
effect of saturated fat consumption on CVD risk, the positive 
association noted in the current data between saturated fat 
and HDL concentrations must be interpreted with caution, as 
saturated fat intake was also associated with total cholesterol 
concentrations in the Paleolithic groups and may result in 
increased CVD risk over a longer-term period. Furthermore, 
we found a positive association between saturated fat intake, 
body weight, and BMI, which are known to increase CVD 
risk [70]. Taken together with the greater observed serum 
TMAO concentrations, it cannot be concluded that the Paleo-
lithic diet is associated with improved gut health and a reduc-
tion in risk of CVD as promoted [71, 72].
Conclusion
The cross-sectional data collected suggests that long-term 
adherence to the Paleolithic diet may not be beneficial for gut 
health, due to the association with lower relative abundances 
Fig. 3  a–c Significant contributors to genera differences between groups. Bar graphs show relative abundances by dietary group. **P < 0.01 dif-
ference between control and PP/SP groups
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of known beneficial bacterial genera, and the increased rela-
tive abundance of TMA producing genera Hungatella. Our 
findings highlight that further research is required to under-
stand the role of vegetables and saturated fat and how they 
influence colonic uptake of SCFA and subsequent excretion. 
The rationale to exclude whole grains is not supported by 
data presented here; being inversely associated with body 
weight and TMAO concentrations. Despite the maintenance 
of SCFA excretion, and stool frequency and form, the differ-
ences noted in microbiota composition associated with the 
high fat and low carbohydrate intake may not be beneficial 
for long-term health.
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